Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cephalanoploris Herba is a traditional Chinese medicinal herb derived from the dried aerial parts of *Cephalanoplos segetum* (also known as *Cirsium setosum*). It is widely recognized for its hemostatic, anti-inflammatory, and detoxifying properties. In clinical practice, it is primarily used to treat various bleeding disorders, including hematemesis, epistaxis, hematuria, and functional uterine bleeding, by "cooling the blood" and promoting coagulation. It also possesses the ability to resolve blood stasis and reduce swelling, making it effective for treating traumatic injuries, carbuncles, and skin infections. The pharmacological effects are attributed to its diverse chemical constituents, including flavonoids like linarin, phenolic acids, and alkaloids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cephalanoploris herba.